Meet the PreComb Team

Founded in 2018, PreComb was created by three accomplished serial entrepreneurs possessing diverse and complementary expertise in areas such as cell culture technology, tissue engineering, product development, data management, biopharmaceutical development, drug manufacturing, and laboratory automation. With experience gained from their executive leadership roles at renowned organizations like Novartis, Alcon, InSphero, ESBATech, and Insilico Biotechnology, the founders bring a wealth of knowledge in promoting innovation, developing talent, advancing technology, establishing companies, and executing operations.

Hal Bosher

CEO

Hal Bosher is a seasoned finance and fintech executive with extensive experience leading institutions in emerging markets. He has held leadership roles at the World Bank Group and serves on the boards of major financial entities across Asia, bringing deep expertise in investment, digital finance, and strategic growth. With a strong academic background in economics, international finance, and Southeast Asia, he offers valuable insight at the intersection of financial innovation and development—highly relevant to advancing life science ventures in complex markets.

hall-ceo
jens-cofounder

Jens M. Kelm, PhD

Co-founder & CEO

Jens is a pioneer in the field of 3D microtissue culture technology and was one of its early developers. As the founder, president, and CSO of InSphero AG, he helped commercialize some of the earliest physiological 3D models, assays, and screening concepts. Jens also co-founded the Swiss competence center for 3D cell culture technologies (TEDD) and is a member of the steering committee for the 3DCC conference series, organized by DECHEMA. With over 50 publications and 11 patents in the field, Jens holds a PhD in Biotechnology from ETH Zürich.

Etienne Cousin

Strategy & Operations Lead

Etienne is a biotech operator and strategist. He previously worked as a Life Sciences Strategy Consultant at LEK Consulting and Trinity Life Sciences in London, completing 40+ projects for large pharma and biotech companies, spanning commercial strategy, M&A, pricing, and market access. Prior to this, Etienne earned his MSc in Biotechnology at Imperial College London and Undergraduate degree in Biological Sciences from Oxford University

etienne
Micaela Freitas

Micaela F. Freitas Misakyan, PhD

Project Manager

Micaela is a research scientist who specializes in cancer cell biology and 3D cell culture technologies. With her extensive knowledge and experience, she contributes significantly to the field of cancer research. Micaela earned her PhD in Pharmaceutical Sciences from the University of Geneva, further strengthening her credentials and expertise.

Claire Beckers, PhD

Head of Laboratory & Automation

Claire gained extensive experience in 3D microtumor generation and high-throughput drug screening during her PhD and postdoctoral research at the University of Zurich. Her work primarily focused on combined treatment modalities, drug repurposing, and new strategies to overcome cancer treatment resistance. She holds a master’s degree in Drug Development and gained valuable industry experience during her master’s thesis research in the R&D department of UCB in Belgium.

claire

Founders at a glance

  • Over 50 years of combined experience in startups, biotech, and global pharma
  • Serial entrepreneurs with 3 biotech companies founded
  • 2 major biotech exits led and supported
  • 20 years of expertise in 3D tissue models
  • More than 50 publications and 12 patents published
  • Technical development of a commercial drug
  • Profound expertise in lab automation, data science, and AI
Board and Advisors